Search by Drug Name or NDC
NDC 43063-0979-01 BENZONATATE 200 mg/1 Details
BENZONATATE 200 mg/1
BENZONATATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 43063-0979-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Benzonatate
Product Information
| NDC | 43063-0979 |
|---|---|
| Product ID | 43063-979_00767a8a-9c07-26a0-e063-6294a90a312f |
| Associated GPIs | 43102010000110 |
| GCN Sequence Number | 044168 |
| GCN Sequence Number Description | benzonatate CAPSULE 200 MG ORAL |
| HIC3 | H6C |
| HIC3 Description | ANTITUSSIVES, NON-OPIOID |
| GCN | 93007 |
| HICL Sequence Number | 001929 |
| HICL Sequence Number Description | BENZONATATE |
| Brand/Generic | Generic |
| Proprietary Name | BENZONATATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | BENZONATATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZONATATE |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040682 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43063-0979-01 (43063097901)
| NDC Package Code | 43063-979-01 |
|---|---|
| Billing NDC | 43063097901 |
| Package | 100 CAPSULE in 1 BOTTLE, PLASTIC (43063-979-01) |
| Marketing Start Date | 2019-05-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |